Alpa Laboratories Limited (NSE:ALPA)

India flag India · Delayed Price · Currency is INR
63.79
+1.64 (2.64%)
Mar 10, 2026, 10:13 AM IST
-41.36%
Market Cap 1.31B
Revenue (ttm) 1.14B
Net Income (ttm) 116.09M
Shares Out 21.04M
EPS (ttm) 5.52
PE Ratio 11.26
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,322
Average Volume 21,530
Open 63.63
Previous Close 62.15
Day's Range 62.74 - 63.81
52-Week Range 60.22 - 120.50
Beta 0.53
RSI 35.92
Earnings Date Feb 11, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India. [Read more]

Sector Healthcare
Founded 1988
Employees 453
Stock Exchange National Stock Exchange of India
Ticker Symbol ALPA
Full Company Profile

Financial Performance

In fiscal year 2025, Alpa Laboratories's revenue was 1.12 billion, an increase of 3.41% compared to the previous year's 1.09 billion. Earnings were 195.03 million, an increase of 16.25%.

Financial Statements

News

There is no news available yet.